PLEA was launched in May this year and is already reaching and supporting hundreds of people across the UK fighting
PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new
EXPECT to see a significant uptick in market flotations of domestic and global medical cannabis companies after UK financial regulators
A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of medicinal cannabis prescriptions
A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical
ONE of the UK’s first market-listed medical cannabis and CBD companies has been sold to Canadian producer Stillcanna for over
MEDICINAL cannabis prescribing could be handed over to the UK’s private clinics in a move which would free up access
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
